HealthMylan To Pay $465 Million Over EpiPen Medicaid Rebate Classification Mylan has agreed to pay $465 million after lawmakers and health officials said it wrongly classified EpiPen as a generic product. The classification allowed the pharmaceutical company to pay lower rebates for Medicaid program.by Rhodi Lee
HealthVegan Mom Who Fed 11-Month-Old Baby Nuts And Berries Charged For Child Endangermentby Rhodi Lee
HealthWorld’s First Womb Transplant Lets Woman Give Birth From The Same Uterus She Was Born Fromby Livia Rusu
HealthBreast Cancer Screening Risks And Benefits: What You Need To Know About Mammogramsby Livia Rusu
HealthExploding E-Cigarettes Cause Injuries So Severe Victims Have To Go To Burn Centersby Livia Rusu
HealthDEA Reducing Amount Of Opioid Medication Manufactured In The US By 25 Percent In 2017by Saranya Palanisamy
HealthUS Lawmakers To Investigate WHO Cancer Agency, Question NIH Officials About Fundingby Livia Rusu
HealthE-Cigarettes Are Supposed To Help Smokers Quit, So Why Are They Sending So Many Of Them To The Hospital?by Jelani James
HealthAFM: Possible Causes And Symptoms Of Polio-Like Disease Causing Paralysis In US Childrenby Rhodi Lee
HealthOhio Bridal Shop Suing Texas Hospital Whose Negligence Got It Called The ‘Ebola Store’by Livia Rusu
First Look at Nintendo's Live-Action 'The Legend of Zelda' Movie Starring Bo Bragason and Benjamin Evan Ainsworth